High SDF-1 expression in HIV-1 carriers does not correlate with CD8+ T- cell-mediated suppression of viral replication

Virology

Volumn 244, Issue 2, 1998, Pages 467-472

  Ohashi, Takashi ^a   Arai, Masaaki ^a   Kato, Hirotomo ^a,b   Kubo, Makoto ^a,c   Fujii, Masahiro ^a   Yamamoto, Naoki ^a   Iwamoto, Aikichi ^b   Kannagi, Mari ^a,c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

AIDS; Asymptomatic carriers; HIV 1 carriers; Latent period; Viral replication

Indexed keywords

CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LATENT PERIOD; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; PRIORITY JOURNAL; STROMA CELL; SUPPRESSOR CELL; VIRUS CARRIER; VIRUS EXPRESSION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032503246     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9151     Document Type: Article

References (32)

1. Al-Khatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
2. Arai M., Ohashi T., Tsukahara T., Murakami T., Hori T., Uchiyama T., Yamamoto N., Kannagi M., Fujii M. Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF. Virology. 241:1998;298-303.
3. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996a;829-833.
4. Bleul C. C., Fuhlbrigge R. C., Casasnovas J. M., Aiuti A., Springer T. A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1996b;1101-1119.
5. +. Cell. Immunol. 132:1991;246-255.
6. +. AIDS Res. Hum. Retroviruses. 9:1993;1079-1086.
7. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques. 15:1993;532-534.
8. -+. Science. 270:1995;1811-1815.
9. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
10. Dougherty J. P., Wisniewski R., Yang S. L., Rhode B. W., Temin H. M. New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J. Virol. 63:1989;3209-3212.
11. +-. Nature. 381:1996;667-673.
12. Fauci A. S. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science. 262:1993;1011-1018.
13. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
14. Harada S., Kobayashi N., Koyanagi Y., Yamamoto N. Clonal selection of human immunodeficiency virus (HIV): Serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV). Virology. 158:1987;447-451.
15. +. J. Immunol. 140:1988;2237-2242.
16. +. J. Virol. 64:1990;3399-3406.
17. Lacey S. F., McDanal C. B., Horuk R., Greenberg M. L. The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8(+) T cell suppression of syncytia-inducing strains of HIV-1. Proc. Natl. Acad. Sci. USA. 94:1997;9842-9847.
18. Langlade-Demoyen P., Michel F., Hoffenbach A., Vilmer E., Dadaglio G., Garicia-Pons F., Mayaud C., Autran B., Wain-Hobson S., Plata F. Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes. J. Immunol. 141:1988;1949-1957.
19. +. Immunol. Today. 17:1996;217-224.
20. Ljunggren K., Bottiger B., Biberfeld G., Karlson A., Fenyo E. M., Jondal M. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J. Immunol. 139:1987;2263-2267.
21. McKenzie S. W., Dallalio G., North M., Frame P., Means R. T. Jr. Serum chemokine levels in patients with non-progressing HIV infection. Aids. 10:1996;F29-F33.
22. Nagasawa T., Kikutani H., Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl. Acad. Sci. USA. 91:1994;2305-2309.
23. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J. L., Arenzana-Seisdedos F., Schwartz O., Heard J. M., Clark-Lewis I., Legler D. F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
24. Ojo-Amaize E. A., Nishanian P., Keith D. E. Jr., Houghton R. L., Heitjan D. F., Fahey J. L., Giorgi J. V. Antibodies to human immunodeficiency virus in human sera induce cell- mediated lysis of human immunodeficiency virus-infected cells. J. Immunol. 139:1987;2458-2463.
25. Planelles V., Bachelerie F., Jowett J. B., Haislip A., Xie Y., Banooni P., Masuda T., Chen I. S. Fate of the human immunodeficiency virus type 1 provirus in infected cells: A role for vpr. J. Virol. 69:1995;5883-5889.
26. +. Clin. Exp. Immunol. 91:1993;473-481.
27. Sattentau Q. J., Weiss R. A. The CD4 antigen: Physiological ligand and HIV receptor. Cell. 52:1988;631-633.
28. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., Honjo T. Signal sequence trap: A cloning strategy for secreted proteins and type I membrane proteins. Science. 261:1993;600-603.
29. Tersmette M., Lange J. M., de Goede R. E., de Wolf F., Eeftink-Schattenkerk J. K., Schellekens P. T., Coutinho R. A., Huisman J. G., Goudsmit J., Miedema F. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet. 1:1989;983-985.
30. Walker B. D., Chakrabarti S., Moss B., Paradis T. J., Flynn T., Durno A. G., Blumberg R. S., Kaplan J. C., Hirsch M. S., Schooley R. T. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 328:1987;345-348.
31. +. Science. 234:1986;1563-1566.
32. Weiss R. A., Clapham P. R., Weber J. N., Dalgleish A. G., Lasky L. A., Berman P. W. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature. 324:1986;572-575.